LCI 1382 (Clindamycin 150 mg)
Pill imprint LCI 1382 has been identified as Clindamycin hydrochloride 150 mg.
Clindamycin is used in the treatment of bacterial infection; skin or soft tissue infection; sinusitis; bacterial vaginitis; bacterial endocarditis prevention (and more), and belongs to the drug class lincomycin derivatives. There is no proven risk in humans during pregnancy. Clindamycin 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- LCI 1382
- Strength:
- 150 mg
- Color:
- Blue / Green
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Lincomycin derivatives
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1382
- Inactive Ingredients:
- lactose monohydrate
corn starch
magnesium stearate
magnesium silicate
gelatin
D&C Red No. 33
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Green No. 3
titanium dioxide
shellac
alcohol
isopropyl alcohol
ammonia
butyl alcohol
propylene glycol
silicon dioxide
More about clindamycin
Consumer resources
- Clindamycin
- Clindamycin solution
- Clindamycin suspension
- Clindamycin oral/injection
- Clindamycin (Advanced Reading)
- Clindamycin Oral, Injection, Intravenous (Advanced Reading)
- Other brands: Cleocin, Cleocin Phosphate, Cleocin HCl, Cleocin Pediatric
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
